diabetes

Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Yahoo/Business Wire
Sun, 06/7/09 - 08:55 am
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
diabetes
Halozyme's Phase 2 Insulin-PH20 Study Demonstrates Faster Insulin Absorption and Superior Glucose Control in Type 1 Diabetic Patients
Yahoo/BusinessWire
Sun, 06/7/09 - 08:52 am
Halozyme
diabetes
AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
Yahoo/PR Newswire
Sun, 06/7/09 - 08:51 am
MannKind
Afresa
diabetes
Boehringer Ingelheim Unveils Diabetes Pipeline
PR Newswire
Sat, 06/6/09 - 12:40 pm
Boehringer Ingelheim
pipelines
diabetes
Lilly’s Once-Weekly Byetta Outperforms Actos, Januvia in Study
Bloomberg
Sat, 06/6/09 - 12:38 pm
Eli Lilly
Byetta
Amylin
Januvia
Merck
diabetes
Lilly: positive results on diabetes treatment
Marketwatch
Sat, 06/6/09 - 12:37 pm
Eli Lilly
drug trials
diabetes
Drugmakers pitch meds in the works for diabetes
Yahoo/AP
Sat, 06/6/09 - 10:17 am
diabetes
Amylin
Byetta
Eli Lilly
Bristol-Myers Squibb
GSK
PPD shares fall on diabetes drug setback
Yahoo/AP
Thu, 06/4/09 - 12:41 pm
PPD
diabetes
Takeda
Merck
alogliptin
Schering Plough
Takeda to Delay New Diabetes Drug Filing in Europe
Bloomberg
Thu, 06/4/09 - 08:56 am
diabetes
Takeda
Europe
alogliptin
CombinatoRx reports positive trial results
Bizjournals.com
Thu, 05/28/09 - 09:11 am
CombinatoRx
drug trials
diabetes
Merck, CIGNA Prove It Pays to Be Healthy
Seeking Alpha
Fri, 05/22/09 - 10:03 am
Merck
Cigna
diabetes
FDA approves generic version of diabetes treatment Precose for Impax Laboratories
Yahoo/AP
Tue, 05/19/09 - 10:22 am
FDA
generics
Precose
Impax
diabetes
FDA Accepts MannKind's Submission and Files NDA for AFRESA
Yahoo
Mon, 05/18/09 - 11:52 am
FDA
MannKind
diabetes
Afresa
Diabetes drug gets FDA nod, but who'll sell it?
Fierce Pharma
Thu, 05/7/09 - 08:38 pm
FDA
Onglyza
diabetes
Cycloset
VeroScience
Is Amylin caving to proxy pressure?
Fierce Pharma
Thu, 05/7/09 - 10:30 am
Amylin
diabetes
Amylin Seeks FDA Approval on Extended Byetta Treatment
WSJ Online
Tue, 05/5/09 - 10:35 am
Amylin
FDA
Byetta
diabetes
Amylin and Lilly partner to develop new pen device for diabetes therapy
Pharmaceutical Business Review
Fri, 05/1/09 - 10:45 am
diabetes
Amylin
Eli Lilly
partnerships
exanitide
Novo Nordisk postpones pre-launch physician training for liraglutide
FT.com
Tue, 04/28/09 - 08:41 am
Novo Nordisk
Victoza
diabetes
FDA Extends Bristol Diabetes Drug Deadline
TheStreet.com
Fri, 04/24/09 - 06:12 am
FDA
diabetes
Bristol-Myers Squibb
Onglyza
FDA Calendar Updates: Diabetes
Seeking Alpha
Thu, 04/23/09 - 09:49 am
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Onglyza
alogliptin
Takeda
Novo Nordisk
Victoza

Pages